CannabisNewsBreaks

MondayJun 06, 2022 2:08 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Takes First Regulatory Step with FDA for Development of DehydraTECH-CBD in Treating Hypertension

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has successfully filed a pre-Investigational New Drug (“IND”) meeting request letter with the U.S. Food and Drug Administration (“FDA”). According to the update, the FDA has already responded to and confirmed Lexaria’s filing and has provided a target date of July 30, 2022, subject to certain conditions being met. “We are excited to take this important first regulatory step with the FDA for the development of our DehydraTECH-CBD for the treatment of hypertension,” said John Docherty, president of Lexaria. “Submission of this request letter…

Continue Reading

FridayJun 03, 2022 3:32 pm

CannabisNewsBreaks – Advanced Container Technologies Inc.’s (ACTX) Innovative Growing Systems Offering Numerous Advantages

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of GrowPods, is seeing interest in the environmentally controlled micro-farms that allow cultivation of ultraclean crops year-round. According to a recent article that contains excerpts from a GreenBiz piece titled, “How Vertical and Indoor Farming Can Supplement the Food Supply Chain,” innovators have developed new technologies such as indoor and vertical farms designed to supplement outdoor farming and solve the issue of limited cultivation land. The piece notes that “the systems often recirculate water, which can be more efficient than how water is used for other types of crops. Light and…

Continue Reading

FridayJun 03, 2022 2:29 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Awards Exclusive License to Japan’s Premier Wellness Science Co.

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has awarded licensing of its proprietary DehydraTECH(TM) offering for development in Japan to Premier Wellness Science Co. Ltd, a wholly owned subsidiary of Premier Anti-Aging Co. Ltd. LEXX announced that Premier is purchasing exclusive rights to DehydraTECH technology for the Japanese nonpharmaceutical market; the company will use the tech in oral liquid and nonliquid products, as well as for topical, hair-care, lip-care and cosmetics products. According to the announcement, Lexaria will receive minimum payments of $4,527,500 over the next five years, as all well as royalties from the sales of products…

Continue Reading

ThursdayJun 02, 2022 2:05 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) DehydraTECH Footprint Extends to Europe with License Granted to Valcon Medical

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has awarded licensing of its proprietary DehydraTECH(TM) offering for development in the European and United Kingdom markets. The company awarded the nonexclusive licenses to Valcon Medical A/S, a European contract manufacturing organization that specializes in the manufacturing of medical cannabis extracts for the EU and UK. According to the announcement, Lexaria will receive milestone fees and royalty payments from sales of products manufactured by Valcon.Valcon products will include an array of options, from nonregistered medical products through magistral programs to country-level market-authorized medical cannabis products through pilot programs; they will…

Continue Reading

ThursdayJun 02, 2022 11:40 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces $5M Registered Direct and Private Placement Offerings

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the research, development, manufacturing and commercialization of rare cannabinoids. The company today announced its entry into securities purchase agreements with a single health care-focused institutional investor for the issuance and sale of 4,079,256 of its common shares, each at a purchase price of $0.858 (or pre-funded warrant in lieu thereof), in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, InMed has also agreed to issue and sell to the investor 1,748,250 common shares (or pre-funded warrant in lieu thereto) at the same purchase price as in…

Continue Reading

WednesdayJun 01, 2022 1:43 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports on 2022 Annual Meeting Voting

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has released a report on its recent 2022 Annual Meeting and the items that were voted on. The meeting was held on May 31, 2022, at 1 p.m. PT. According to the announcement, 2,927,321 shares of the company were represented in person or by proxy during the meeting; that number comprised 49.2% of Lexaria’s issued share capital as of April 4, 2022, which is the record date of the meeting. All matters voted on during the meeting were passed by a majority. Those matters included electing Chris Bunka, John Docherty,…

Continue Reading

TuesdayMay 31, 2022 12:44 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Launch of JustCBD Products on Amazon.co.uk

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that its wholly-owned subsidiary JustCBD will be launching its line of Novel Foods-registered CBD products on Amazon.co.uk. Since its entry into the now £700 million CBD market in October 2021, Amazon U.K. has expanded the initial pilot-only program to include vendors who have demonstrated compliance with U.K. CBD Novel Food regulations. Producers awarded U.K. Novel Food authorization must prove the product is safe for consumption and labeled correctly. “With health and wellness playing an increasingly important role in customers’ lives, we are…

Continue Reading

FridayMay 27, 2022 2:57 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging DehydraTECH(TM) as It Looks to Tap into Various Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX) has been pushing the boundaries of drug delivery through its patented DehydraTECH(TM) technology, which has evidenced more efficient delivery of active pharmaceutical ingredients (“APIs”) into the bloodstream while also increasing their bioavailability. “Its technology has seen application in pharmaceuticals, nutraceuticals, consumer packaged goods, and over-the-counter capsules, pills, tablets, and oral suspensions. Lexaria has explored its usage in the delivery of cannabinoids, nicotine, antivirals, PDE5 inhibitors, and more,” a recent article reads. “All of Lexaria’s efforts serve to demonstrate the superior performance of both its research program and its DehydraTECH drug delivery technology. By doing so,…

Continue Reading

FridayMay 27, 2022 1:10 pm

CannabisNewsBreaks – Sugarmade Inc. (SGMD) Differentiating Itself in Competitive Cannabis Space

Sugarmade (OTC: SGMD) has once again showed its expertise in savvy business strategy. “The cannabis space is known for its competition, but Sugarmade, an emerging leader in the sector, has distinguished itself by its smart, creative decisions,” a recent article reads. “Last month, Sugarmade entered into a definitive agreement designed to expand its cannabis delivery footprint. The agreement established SGMD’s majority ownership in a fully licensed new Hollywood cannabis delivery hub located on the world-famous Sunset Strip. Based on the agreement, the company will receive 100% of all profits from the new delivery hub until it has made back its…

Continue Reading

FridayMay 27, 2022 11:52 am

CannabisNewsBreaks – Lift&Co. Expo Toronto Showcased Innovations Powering Future of the Cannabis Sector

Lift&Co. Expo, Canada’s no. 1 cannabis conference and trade show, hosted its latest event on May 12-15, 2022, at the Metro Toronto Convention Centre. The Lift Cannabis Business Conference (May 12) and Lift&Co. Expo in the Centre’s North Hall (May 13-15) featured leading-edge content and exhibitors from across North America to showcase information and innovations powering the future of the cannabis industry. Event sessions included Next Gen Cannabis Innovations, New Big Product Categories and Cannabis Market Trends & Predictions. The expo also shined the spotlight on additional forward-thinking programming across both the cannabis and psychedelics sectors and covered engaging topics…

Continue Reading